Literature DB >> 15226878

Giant lymph node hyperplasia of the mediastinum (Castleman's disease).

M A Bhatti1, J W Ferrante, I Gielchinsky, J C Norman.   

Abstract

Giant lymph node hyperplasia is a rare, benign disease involving lymph nodes in various locations, predominantly in the mediastinum. There are two variants: plasma cell (earlier and/or acute) and hyaline-vascular, more chronic with an intermediate transitional type. The usual presentation is a solitary well-circumscribed asymptomatic mass lesion, often attaining large size, with infrequent associated hematologic manifestations. A case of giant lymph node hyperplasia involving the paravertebral superior mediastinum is reported. Surgical excision was the treatment of choice in a 65-year-old man, and at thoractomy, an encapsulated mass was excised from the posterior superior mediastinum. The patient had an uneventful postoperative course and was discharged on the tenth postoperative day. Three years later, he is well and employed as a carpenter.

Entities:  

Year:  1984        PMID: 15226878      PMCID: PMC351713     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  24 in total

1.  Localized mediastinal lymphnode hyperplasia resembling thymoma.

Authors:  B CASTLEMAN; L IVERSON; V P MENENDEZ
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

2.  Benign lymphoid masses of probable hamartomatous nature. Analysis of 12 cases.

Authors:  R LATTES; M R PACHTER
Journal:  Cancer       Date:  1962 Jan-Feb       Impact factor: 6.860

3.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

4.  Plasma cell giant lymph node hyperplasia responding to radiation therapy.

Authors:  D G Nordstrom; H H Tewfik; H B Latourette
Journal:  AJR Am J Roentgenol       Date:  1978-01       Impact factor: 3.959

5.  Giant lymph node hyperplasia of the mediastinum.

Authors:  D R Craddock; M J Peacock; P W Allen
Journal:  Med J Aust       Date:  1974-05-18       Impact factor: 7.738

6.  Angiomatous lymphoid hamartoma associated with chronic anemia, hypoferremia, and hypergammaglobulinemia.

Authors:  L A Boxer; G J Boxer; R C Flair; P F Engstrom; G S Brown
Journal:  J Pediatr       Date:  1972-07       Impact factor: 4.406

7.  Extrathoracic angiofollicular lymphoid hyperplasia with coincidental myasthenia gravis.

Authors:  H E Emson
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

8.  Giant mediastinal lymph node hyperplasia (Castleman's disease): angiographic and clinical features.

Authors:  J F Walter; R W Rottenberg; W B Cannon; L A Sheridan; J Pizzimenti; J T Orr
Journal:  AJR Am J Roentgenol       Date:  1978-03       Impact factor: 3.959

9.  Giant lymph-node hyperplasia, plasma-cell type, of the mediastinum, with peripheral neuropathy.

Authors:  G S Yu; J W Carson
Journal:  Am J Clin Pathol       Date:  1976-07       Impact factor: 2.493

10.  Remission of giant lymph node hyperplasia with anemia after radiotherapy.

Authors:  D D Weisenburger; R L DeGowin; P Gibson; J O Armitage
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

View more
  1 in total

1.  Castleman's disease and sarcoidosis, a rare association resulting in a "mixed" response: a case report.

Authors:  Anwarullah Mohammed; Filip Janku; Ming Qi; Razelle Kurzrock
Journal:  J Med Case Rep       Date:  2015-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.